# Design time for an OpenMRS Distribution focusing on Cystic Fibrosis **URL:** \ **Category:** Development\ **Tags:** design-forum\ **Created:** [February 20, 2019, 6:34pm UTC](https://talk.openmrs.org/t/design-time-for-an-openmrs-distribution-focusing-on-cystic-fibrosis/21840 "2019-02-20T18:34:33Z")\ **Posts on this page:** 9\ **Page:** 1
**Author:** ![burke](https://talk.openmrs.org/user_avatar/talk.openmrs.org/burke/32/17_2.png) [@burke](https://talk.openmrs.org/u/burke)\ **Post date:** [February 20, 2019, 6:34pm UTC](https://talk.openmrs.org/t/design-time-for-an-openmrs-distribution-focusing-on-cystic-fibrosis/21840/1 "2019-02-20T18:34:33Z")
Continuing the discussion from [Propose a Design Forum Topic](https://talk.openmrs.org/t/propose-a-design-forum-topic/11596/54) per our [conventions](https://talk.openmrs.org/t/issues-arranging-design-forum-calls/19416/2): > [@Propose a Design Forum Topic](https://talk.openmrs.org/t/propose-a-design-forum-topic/11596/54): > > I’d like to propose this design call: > > **Title:** An OpenMRS Distribution focusing on Cystic Fibrosis > > **Description** : We are a team (the Representative of Iran Cystic Fibrosis (CF) Association) with high creative performance, working on clinical data of patients with cystic fibrosis (CF) professionally. Our focus is on design a platform (CF package) for patients and providers to help them and improve the quality of life of this group of patients. CF package includes some main parts such as professional registry; monitor and follow-up of patients; correlative analysis on image, sequencing (NGS), transcriptomics, proteomics, and fluxomics; predictive analysis based on correlative analysis via machine learning, expert systems, and intelligence artificial algorithms. Any developers or technical implementers with experience and opinions regarding the adoption or retirement of programming languages, modules/distributions, platforms, or standards/conventions are encouraged to join. > > **Goal:** We are looking for feedback from the community on our project, so that we can continue to improve it before building an interactive prototype. > > **Required attendee(s)** : All interested. if available: @darius, @c.antwi, @jthomas, @mksd, @mogoodrich, @mseaton, @ssmusoke, @burke, @dkayiwa > > **Desired timing** : February 18, 2019 > > Thanks, Najme ---
**Author:** ![c.antwi](https://talk.openmrs.org/user_avatar/talk.openmrs.org/c.antwi/32/7911_2.png) [@c.antwi](https://talk.openmrs.org/u/c.antwi)\ **Post date:** [February 11, 2019, 10:57am UTC](https://talk.openmrs.org/t/design-time-for-an-openmrs-distribution-focusing-on-cystic-fibrosis/21840/2 "2019-02-11T10:57:47Z")
Hi @najme thanks for the great introduction! I do look forward to the presentation and ask that everyone attend to learn more. ---
**Author:** ![najme](https://talk.openmrs.org/letter_avatar/najme/32/5_5575768a8748004e209b776fc1b2916d.png) [@najme](https://talk.openmrs.org/u/najme)\ **Post date:** [February 18, 2019, 10:27am UTC](https://talk.openmrs.org/t/design-time-for-an-openmrs-distribution-focusing-on-cystic-fibrosis/21840/3 "2019-02-18T10:27:24Z")
Dear Cynthia Antwi Our developer lives in Sweden, he has just let me know that he cannot be available today for an unpredictable problem he faced. So I want to ask you to change the time for our design call. If possible, We want to present on March 4, 2019. Thanks Najme ---
**Author:** ![c.antwi](https://talk.openmrs.org/user_avatar/talk.openmrs.org/c.antwi/32/7911_2.png) [@c.antwi](https://talk.openmrs.org/u/c.antwi)\ **Post date:** [February 19, 2019, 12:53pm UTC](https://talk.openmrs.org/t/design-time-for-an-openmrs-distribution-focusing-on-cystic-fibrosis/21840/4 "2019-02-19T12:53:25Z")
Hi @najme No problem we can postpone the meeting to March 4th ---
**Author:** ![c.antwi](https://talk.openmrs.org/user_avatar/talk.openmrs.org/c.antwi/32/7911_2.png) [@c.antwi](https://talk.openmrs.org/u/c.antwi)\ **Post date:** [February 20, 2019, 11:22am UTC](https://talk.openmrs.org/t/design-time-for-an-openmrs-distribution-focusing-on-cystic-fibrosis/21840/5 "2019-02-20T11:22:25Z")
Hi @najme would you be able to shift the presentation to Monday March 11th? I am having a scheduling conflict with another team. kindly confirm ---
**Author:** ![najme](https://talk.openmrs.org/letter_avatar/najme/32/5_5575768a8748004e209b776fc1b2916d.png) [@najme](https://talk.openmrs.org/u/najme)\ **Post date:** [February 21, 2019, 4:38pm UTC](https://talk.openmrs.org/t/design-time-for-an-openmrs-distribution-focusing-on-cystic-fibrosis/21840/6 "2019-02-21T16:38:59Z")
Hi Yes it is possible. we can shift the presentation to Monday March 11th. Thanks ---
**Author:** ![c.antwi](https://talk.openmrs.org/user_avatar/talk.openmrs.org/c.antwi/32/7911_2.png) [@c.antwi](https://talk.openmrs.org/u/c.antwi)\ **Post date:** [February 21, 2019, 5:49pm UTC](https://talk.openmrs.org/t/design-time-for-an-openmrs-distribution-focusing-on-cystic-fibrosis/21840/7 "2019-02-21T17:49:59Z")
Great Thank You! ---
**Author:** ![c.antwi](https://talk.openmrs.org/user_avatar/talk.openmrs.org/c.antwi/32/7911_2.png) [@c.antwi](https://talk.openmrs.org/u/c.antwi)\ **Post date:** [March 8, 2019, 2:31pm UTC](https://talk.openmrs.org/t/design-time-for-an-openmrs-distribution-focusing-on-cystic-fibrosis/21840/8 "2019-03-08T14:31:42Z")
Hi @najme Is your team ready for the presentation on Monday March 11? I would like to do an announcement to the community for the design forum call ---
**Author:** ![najme](https://talk.openmrs.org/letter_avatar/najme/32/5_5575768a8748004e209b776fc1b2916d.png) [@najme](https://talk.openmrs.org/u/najme)\ **Post date:** [March 10, 2019, 5:52pm UTC](https://talk.openmrs.org/t/design-time-for-an-openmrs-distribution-focusing-on-cystic-fibrosis/21840/9 "2019-03-10T17:52:24Z")
Dear Cynthia Antwi I hope you are fine. During these two weeks, I did my best to communicate with CF foundation. Fortunately, president of CF foundation has replied me and is supposed to set a Skype meeting to discuss about our scientific work. Since I have been doing my best to get ready for this presentation, I was not available. So sorry for my delay. I plan to present our work and discuss with CF foundation and the critical people in this field (Cystic fibrosis) to validate our analysis. Then I want to present our work in your group. Because I think introduction of our work has two steps. First, is to introduce the analysis for CF patients with our algorithm to CF foundation and second, is to combine the analysis of CF parameters and CF registry via OpenMRS software. So, I will let you know by the end of this week about the results and the time of our presentation in your group. I am sure this work will be prefect with the help of CF foundation and your team. Best, Najme